首页> 外国专利> methods of determining the efficacy of therapy in the treatment of amyloidosis and of identifying patients as prodromal for disease associated with amyloid deposition and its compounds

methods of determining the efficacy of therapy in the treatment of amyloidosis and of identifying patients as prodromal for disease associated with amyloid deposition and its compounds

机译:确定治疗淀粉样变性病疗效的方法以及确定患者为淀粉样蛋白沉积及其化合物相关疾病的前驱的方法

摘要

Methods of Determining the Effectiveness of Therapy in the Treatment of Amyloidosis and Identifying the Patient as a Prodromal for Disease Associated with Amyloid Deposition and Compounds thereof The present method for determining the efficacy of therapy in the treatment of amyloidosis involves administering to the patient in need a compound of the amyloidosis. formula (I) or Formula (II) or structures 1-45 and capture patient images. After capturing said images, at least one anti-amyloid agent is administered to said patient. Then, an effective amount of a compound of formula (I) or Formula (II) or structures 1-45 is administered to the patient and the patient is again captured. Finally, baseline levels of patient amyloid deposition prior to anti-amyloid agent treatment are compared with patient amyloid deposition levels following anti-amyloid agent treatment.
机译:确定治疗淀粉样变性病的疗效的方法并确定患者是淀粉样变性相关疾病的前驱体及其化合物本发明的确定治疗淀粉样变性病的疗效的方法涉及对有需要的患者进行治疗。淀粉样变性的化合物。式(I)或式(II)或结构1-45并捕获患者图像。在捕获所述图像之后,向所述患者施用至少一种抗淀粉样蛋白剂。然后,向患者施用有效量的式(I)或式(II)的化合物或结构1-45,并再次捕获患者。最后,将抗淀粉样蛋白治疗之前的患者淀粉样蛋白沉积的基线水平与抗淀粉样蛋白治疗后的患者淀粉样蛋白沉积水平进行比较。

著录项

  • 公开/公告号BRPI0512893A

    专利类型

  • 公开/公告日2008-04-15

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF PITTSBURGH;

    申请/专利号BR2005PI12893

  • 发明设计人 WILLIAM E. KLUNK;CHESTER A. MATHIS JR.;

    申请日2005-07-01

  • 分类号A61K49;A61P3/06;A61P25/28;A61P29;

  • 国家 BR

  • 入库时间 2022-08-21 20:08:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号